Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.845
EU - Europa 7.841
AS - Asia 6.475
Continente sconosciuto - Info sul continente non disponibili 1.164
SA - Sud America 1.155
AF - Africa 160
OC - Oceania 37
Totale 34.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.486
SG - Singapore 2.328
RU - Federazione Russa 1.983
IT - Italia 1.905
CN - Cina 1.756
BR - Brasile 884
DE - Germania 843
FI - Finlandia 800
HK - Hong Kong 692
VN - Vietnam 568
UA - Ucraina 414
PL - Polonia 407
GB - Regno Unito 373
FR - Francia 320
IE - Irlanda 248
JP - Giappone 211
BD - Bangladesh 207
CA - Canada 178
SE - Svezia 149
KR - Corea 142
IN - India 131
NL - Olanda 79
RO - Romania 74
AR - Argentina 70
MX - Messico 68
TR - Turchia 59
CO - Colombia 57
IQ - Iraq 57
ES - Italia 43
BE - Belgio 42
EC - Ecuador 42
ID - Indonesia 41
ZA - Sudafrica 39
AT - Austria 34
VE - Venezuela 33
AU - Australia 31
PK - Pakistan 28
CH - Svizzera 25
EG - Egitto 24
PH - Filippine 24
UZ - Uzbekistan 23
MY - Malesia 22
CL - Cile 21
CR - Costa Rica 21
PY - Paraguay 21
SA - Arabia Saudita 20
AE - Emirati Arabi Uniti 19
IR - Iran 18
JO - Giordania 18
CZ - Repubblica Ceca 17
KE - Kenya 16
MA - Marocco 15
CI - Costa d'Avorio 14
DZ - Algeria 14
HN - Honduras 14
LB - Libano 14
NP - Nepal 14
GR - Grecia 13
JM - Giamaica 13
LT - Lituania 12
BO - Bolivia 11
PA - Panama 11
TW - Taiwan 11
AZ - Azerbaigian 10
EE - Estonia 10
IL - Israele 10
TH - Thailandia 9
TN - Tunisia 9
GE - Georgia 8
KG - Kirghizistan 8
UY - Uruguay 8
ET - Etiopia 7
KZ - Kazakistan 7
NI - Nicaragua 7
PT - Portogallo 7
DK - Danimarca 6
GT - Guatemala 6
NZ - Nuova Zelanda 6
PE - Perù 6
DO - Repubblica Dominicana 5
PR - Porto Rico 5
SN - Senegal 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AL - Albania 4
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
EU - Europa 4
MD - Moldavia 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
HR - Croazia 3
MU - Mauritius 3
AI - Anguilla 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
Totale 33.468
Salva come PNG Salva come JPEG
Città #
Ashburn 1.987
Fairfield 1.915
Singapore 1.644
San Jose 1.210
Woodbridge 985
Seattle 823
Chandler 774
Wilmington 761
Houston 710
Hong Kong 647
Cambridge 616
Ann Arbor 513
Moscow 389
Council Bluffs 387
Zgierz 356
Secaucus 343
Palermo 318
Los Angeles 317
Des Moines 292
Beijing 280
Helsinki 253
Santa Clara 253
Medford 251
Dublin 246
Dallas 228
Jacksonville 207
Chicago 206
New York 203
Tokyo 195
Ho Chi Minh City 180
Nanjing 167
Altamura 162
Lauterbourg 162
Princeton 161
Hefei 149
Frankfurt am Main 142
San Diego 141
Boardman 137
Hanoi 137
Lawrence 124
Milan 119
The Dalles 116
Jinan 90
Buffalo 84
Dearborn 83
Rome 79
Shenyang 69
São Paulo 66
Ludwigshafen am Rhein 63
Tulsa 61
Nanchang 59
Phoenix 58
London 54
Toronto 48
Seoul 47
Tianjin 46
Changsha 45
Hebei 45
Zhengzhou 43
Warsaw 42
Brussels 40
Orem 40
Jiaxing 36
Atlanta 35
Columbus 35
Da Nang 35
Brooklyn 34
Guangzhou 34
Amsterdam 32
Boston 31
Montreal 31
Seongnam 31
Ningbo 30
Bologna 29
Munich 29
Salt Lake City 29
Denver 28
Johannesburg 28
Naples 28
Rio de Janeiro 28
Falls Church 25
Philadelphia 25
Haiphong 24
Kumar 24
North Bergen 24
San Paolo di Civitate 24
Baghdad 23
Poplar 23
Venice 23
Saint Petersburg 22
San Francisco 22
Belo Horizonte 20
Brasília 20
Hangzhou 20
Nuremberg 20
Ottawa 20
Pune 20
Tampa 20
Central 19
Elk Grove Village 19
Totale 21.368
Salva come PNG Salva come JPEG
Nome #
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 1.099
Malattia di KiKuchi-Fujimoto e lupus eritematoso sistemico: quale connessione ?. 534
Intestinal Involvement in Kawasaki Disease 356
Ectopic expression of CXCL13, BAFF, APRIL and LT-ß is associated with artery tertiary lymphoid organs in giant cell arteritis 334
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs 314
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. 309
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. 308
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 307
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response 303
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 300
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 291
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 290
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: A prospective open-label study 290
Associazione tra spondiloartrite e gammopatia monoclonale: tre casi clinici 281
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 279
Downregulation of miRNA17-92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis 274
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 267
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 262
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 262
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 258
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 255
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes 254
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 254
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. 253
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 253
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 253
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 252
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. 250
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 248
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis 247
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 247
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 244
New insights into the pathogenesis of giant cell arteritis 244
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. 244
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome 243
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 243
Ruolo della terapia con aspirina e con immunoglobuline endovena nella poliabortività associata a sindrome da anticorpi anti-fosfolipidi 238
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 237
Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up 236
La determinazione degli anticorpi anti-peptide ciclico citrullinato è utile nel discriminare pazienti con artrite reumatoide da quelli con poliartrite associata a tiroidite cronica autoimmune 234
IL-17 polarization of MAIT cells is derived from the activation of two different pathways 234
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 229
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 228
Arteriosclerosi ed artrite reumatoide: ruolo della terapia biologica 226
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis 226
Atherosclerosis in females patients with rheumatoid arthritis; a two years follow-up. 225
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. 223
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 222
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response 220
Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up 217
Aterosclerosi e artrite reumatoide: ruolo della twerapia biologica 215
Pro-inflammatory CX3CR1+ CD59+ TL1A+ IL-23+ monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions 213
Brief Report: Intestinal dysbiosis in ankylosing spondylitis 212
Disfunzione diastolica in pazienti affetti da artrite reumatoide: ruolo della terapia con anti-TNFα 211
Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications 211
IVIG in APS pregnancy 210
An intense physical rehabilitation program determines pain relief and improves the global quality of life in patients with fibromyalgia 210
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 208
Impatto del trattamento precoce con infliximab + methotrexate ed alte dosi di prednisone (PDN) vs infliximab (IFX) + methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 207
T2-mapping of the sacroiliac joints at 1.5 Tesla: a feasibility and reproducibility study 206
Disfunzione diastolica in pazienti affetti da artrite reumatoide:ruolo della terapia con anti-TNF 204
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 203
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 203
Pathogenesis of polymyalgia rheumatica 202
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 201
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 200
pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease 200
Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis 199
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 194
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 194
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 193
Artropatia sclerodermica ed artrite reumatoide: non evidenza di overlap 192
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 192
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 191
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 190
Athersoclerosis in females patients with rheumatoid arthritis: a two years follow-up 189
Giant cell arteritis associated with chronic active Epstein-Barr virus infection. 188
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 188
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 188
THE LEVEL OF SOLUBLE GRANZYME A IS ELEVATED IN THE PLASMA AND IN THE Vgamma9/Vdelta2 T CELL CULTURE SUPERNATANTS OF PATIENTS WITH ACTIVE BEHCET'S DISEASE 187
Rapida induzione di remissione di un caso di malattia di Vogt-Koyonagi-Harada recidivante dopo terapia con infliximab 187
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 187
Subclinical gut inflammation in ankylosing spondylitis 187
The level of solubile granzyme A is elevated in the plasma and in the Vγ9/Vδ2 T cell culture supernatants of patients with active Behçet's disease. 185
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 185
Micofenolato mofetil nell’alveolite sclerodermica: uno studio pilota 183
Iniezione locale di infliximab nel trattamento della dattilite 182
IBD e malattie reumatiche. Malattia di Crohn e spondilite anchilosante: una patogenesi comune? 182
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 182
Efficacia e sicurezza di infliximab nelle spondiloartriti indifferenziate: follow-up a 2 anni 179
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 179
Profilo citochinico ed espressione di STATS e SOCS nell’intestino di pazienti affetti da spondilite anchilosante 177
Diastolic dysfunction in patients with rheumatoid arthritis treated with TNF blocking agents 177
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 177
Interleukin-9 and T helper type 9 cells in rheumatic diseases 175
Invariant NKT cells and rheumatic disease: Focus on primary sjogren syndrome 175
Impatto del trattamento precoce con infliximab + methotrexate (MTX) ed alte dosi di prednisone (PDN) vs infliximab (IFX)+methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 174
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 174
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 171
Primary sjogren syndrome: Focus on innate immune cells and inflammation 171
Totale 23.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.428 0 0 0 76 56 111 97 143 207 287 129 322
2022/20232.675 276 470 50 251 296 375 242 211 286 37 129 52
2023/20241.187 70 181 73 81 98 247 145 68 24 47 35 118
2024/20253.351 71 220 179 264 125 140 233 220 226 318 415 940
2025/202612.342 749 603 755 1.248 1.144 1.665 1.729 1.147 946 1.348 529 479
2026/20272.149 581 307 1.248 13 0 0 0 0 0 0 0 0
Totale 34.677